This account is no longer associated with Second Sight Medical Products; it now serves as a hub for developments in artificial vision technologies for the blind" title="" class="btn" data-container="body" data-html="true" data-id="48657" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Artificial Vision for the Blind"> 13 650
Activities
Technologies
Entity types
Location
1350 S Loop Rd, Alameda, CA 94502, USA
Alameda
United States of America
Employees
Scale: 11-50
Estimated: 28
Engaged corporates
4Added in Motherbase
5 years, 7 months agoVivani Medical is a pre-clinical-stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortalTM platform, Vivani’s portfolio of tiny, sub-dermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is developing two miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-115 (exenatide) and NPM-139 (semaglutide). In addition, the company is developing NPM-119, a lower dose exenatide implant for the treatment of type 2 diabetes.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() GSK Pharmaceutical, Pharmaceutical Manufacturing | GSK Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Nov 2024 | | |
![]() Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Nov 2024 | | |
![]() | Biotechnology Innovation Organization | Other 31 May 2024 | | |
![]() Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 26 Nov 2014 | |